Integrating AI-Based De Novo Design with Molecular Docking and Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as p53–MDM2 Inhibitors for Triple-Negative Breast Cancer

Dwi Syah Fitra Ramadhan, Regina Dwi Putri Mahardika, Muli Sukmawaty, Kay Khine Soe, Tee Yee Sim, Hooi Chia Tang, Hana Chen

Open source

DOI
10.2174/0115680266474465260825060836
Published
2026-10-26
Container
Current Topics in Medicinal Chemistry
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115680266474465260825060836,
  title = {Integrating AI-Based De Novo Design with Molecular Docking and
Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as
p53–MDM2 Inhibitors for Triple-Negative Breast Cancer},
  author = {Dwi Syah Fitra Ramadhan and Regina Dwi Putri Mahardika and Muli Sukmawaty and Kay Khine Soe and Tee Yee Sim and Hooi Chia Tang and Hana Chen},
  year = {2026},
  journal = {Current Topics in Medicinal Chemistry},
  doi = {10.2174/0115680266474465260825060836},
  url = {https://doi.org/10.2174/0115680266474465260825060836}
}

RIS

TY  - JOUR
TI  - Integrating AI-Based De Novo Design with Molecular Docking and
Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as
p53–MDM2 Inhibitors for Triple-Negative Breast Cancer
AU  - Dwi Syah Fitra Ramadhan
AU  - Regina Dwi Putri Mahardika
AU  - Muli Sukmawaty
AU  - Kay Khine Soe
AU  - Tee Yee Sim
AU  - Hooi Chia Tang
AU  - Hana Chen
PY  - 2026
JO  - Current Topics in Medicinal Chemistry
DO  - 10.2174/0115680266474465260825060836
UR  - https://doi.org/10.2174/0115680266474465260825060836
ER  - 

APA

Ramadhan, D. S. F., Mahardika, R. D. P., Sukmawaty, M., Soe, K. K., Sim, T. Y., Tang, H. C., & Chen, H. (2026). Integrating AI-Based De Novo Design with Molecular Docking and Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as p53–MDM2 Inhibitors for Triple-Negative Breast Cancer. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/0115680266474465260825060836

Source records